Tisdag 26 November | 06:26:43 Europe / Stockholm

Prenumeration

Kalender

Tid*
2026-02-05 08:00 Bokslutskommuniké 2025
2025-10-23 08:00 Kvartalsrapport 2025-Q3
2025-07-16 08:00 Kvartalsrapport 2025-Q2
2025-05-06 08:00 Kvartalsrapport 2025-Q1
2025-02-06 08:00 Bokslutskommuniké 2024
2024-12-18 - Extra Bolagsstämma 2025
2024-10-24 - Kvartalsrapport 2024-Q3
2024-07-17 - Kvartalsrapport 2024-Q2
2024-05-08 - Kvartalsrapport 2024-Q1
2024-04-29 - X-dag ordinarie utdelning ORX 0.00 SEK
2024-04-26 - Årsstämma
2024-02-08 - Bokslutskommuniké 2023
2023-11-02 - Kvartalsrapport 2023-Q3
2023-10-26 - Extra Bolagsstämma 2023
2023-07-18 - Kvartalsrapport 2023-Q2
2023-04-27 - Kvartalsrapport 2023-Q1
2023-04-19 - X-dag ordinarie utdelning ORX 0.00 SEK
2023-04-18 - Årsstämma
2023-01-26 - Bokslutskommuniké 2022
2022-11-03 - Kvartalsrapport 2022-Q3
2022-07-14 - Kvartalsrapport 2022-Q2
2022-04-28 - Kvartalsrapport 2022-Q1
2022-04-22 - X-dag ordinarie utdelning ORX 0.00 SEK
2022-04-21 - Årsstämma
2022-01-27 - Bokslutskommuniké 2021
2021-11-03 - Kvartalsrapport 2021-Q3
2021-07-15 - Kvartalsrapport 2021-Q2
2021-04-29 - Kvartalsrapport 2021-Q1
2021-04-14 - X-dag ordinarie utdelning ORX 0.00 SEK
2021-04-13 - Årsstämma
2021-01-28 - Bokslutskommuniké 2020
2020-11-04 - Kvartalsrapport 2020-Q3
2020-07-16 - Kvartalsrapport 2020-Q2
2020-05-19 - Extra Bolagsstämma 2020
2020-04-28 - Kvartalsrapport 2020-Q1
2020-04-17 - X-dag ordinarie utdelning ORX 0.00 SEK
2020-04-16 - Årsstämma
2020-01-30 - Bokslutskommuniké 2019
2019-10-24 - Kvartalsrapport 2019-Q3
2019-07-11 - Kvartalsrapport 2019-Q2
2019-05-02 - Kvartalsrapport 2019-Q1
2019-04-14 - X-dag ordinarie utdelning ORX 0.00 SEK
2019-04-11 - Årsstämma
2019-01-30 - Bokslutskommuniké 2018
2018-10-25 - Kvartalsrapport 2018-Q3
2018-07-11 - Kvartalsrapport 2018-Q2
2018-04-26 - Kvartalsrapport 2018-Q1
2018-04-13 - X-dag ordinarie utdelning ORX 0.00 SEK
2018-04-12 - Årsstämma
2018-01-25 - Bokslutskommuniké 2017
2017-10-19 - Kvartalsrapport 2017-Q3
2017-07-11 - Kvartalsrapport 2017-Q2
2017-04-20 - Kvartalsrapport 2017-Q1
2017-04-07 - X-dag ordinarie utdelning ORX 0.00 SEK
2017-04-06 - Årsstämma
2017-01-26 - Bokslutskommuniké 2016
2016-10-20 - Kvartalsrapport 2016-Q3
2016-07-12 - Kvartalsrapport 2016-Q2
2016-04-21 - Kvartalsrapport 2016-Q1
2016-04-18 - X-dag ordinarie utdelning ORX 0.00 SEK
2016-04-15 - Årsstämma
2016-01-28 - Bokslutskommuniké 2015
2015-10-22 - Kvartalsrapport 2015-Q3
2015-07-10 - Kvartalsrapport 2015-Q2
2015-04-23 - Kvartalsrapport 2015-Q1
2015-04-16 - X-dag ordinarie utdelning ORX 0.00 SEK
2015-04-15 - Årsstämma
2015-01-29 - Bokslutskommuniké 2014
2014-10-22 - Kvartalsrapport 2014-Q3
2014-10-22 - Analytiker möte 2014
2014-07-11 - Kvartalsrapport 2014-Q2
2014-04-25 - Kvartalsrapport 2014-Q1
2014-04-16 - X-dag ordinarie utdelning ORX 0.00 SEK
2014-04-15 - Årsstämma
2014-01-30 - Bokslutskommuniké 2013
2013-10-23 - Kvartalsrapport 2013-Q3
2013-08-06 - Extra Bolagsstämma 2013
2013-07-12 - Kvartalsrapport 2013-Q2
2013-04-26 - Kvartalsrapport 2013-Q1
2013-04-12 - X-dag ordinarie utdelning ORX 0.00 SEK
2013-04-11 - Årsstämma
2013-03-13 - 15-7 2013
2013-01-31 - Bokslutskommuniké 2012
2012-10-25 - Kvartalsrapport 2012-Q3
2012-09-21 - 15-7 2012
2012-07-13 - Extra Bolagsstämma 2012
2012-07-12 - Kvartalsrapport 2012-Q2
2012-05-03 - Kapitalmarknadsdag 2012
2012-04-27 - Kvartalsrapport 2012-Q1
2012-04-12 - X-dag ordinarie utdelning ORX 0.00 SEK
2012-04-11 - Årsstämma
2012-01-31 - Bokslutskommuniké 2011
2011-11-09 - Kvartalsrapport 2011-Q3
2011-08-10 - Kvartalsrapport 2011-Q2
2011-05-04 - Kvartalsrapport 2011-Q1
2011-04-08 - X-dag ordinarie utdelning ORX 0.00 SEK
2011-04-07 - Årsstämma
2011-02-16 - Extra Bolagsstämma 2011
2011-02-16 - Bokslutskommuniké 2010
2010-11-10 - Kvartalsrapport 2010-Q3
2010-08-20 - Kvartalsrapport 2010-Q2
2010-05-05 - Kvartalsrapport 2010-Q1
2010-04-22 - X-dag ordinarie utdelning ORX 0.00 SEK
2010-04-21 - Årsstämma
2010-02-17 - Bokslutskommuniké 2009
2009-11-10 - Kvartalsrapport 2009-Q3
2009-08-21 - Kvartalsrapport 2009-Q2
2009-05-06 - Kvartalsrapport 2009-Q1
2009-04-24 - X-dag ordinarie utdelning ORX 0.00 SEK
2009-04-23 - Årsstämma

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriLäkemedel & Handel
Orexo är ett svenskt läkemedelsbolag som utvecklar läkemedel baserat på egenutvecklade formuleringsteknologier som möter stora medicinska behov. På den amerikanska marknaden erbjuder Orexo behandlingslösningar för patienter som lider av opioidberoende och närliggande sjukdomar. Produkter som riktar sig till andra terapiområden utvecklas och kommersialiseras världen över i samarbete med partners. Huvudkontoret, där forskning och utvecklingsarbetet bedrivs, ligger i Uppsala.
2024-05-07 10:30:00

In 2023, the Drug Enforcement Agency seized 74.5 million pills containing fentanyl.[i] This record-breaking number helps to explain why so many young people are experiencing unintended fentanyl poisonings. This article explores the risks and why young people are more susceptible to the dangers of taking, and dying from, illicitly manufactured fentanyl pills.

 

Charlie, was just 22 when he overdosed and died after taking what he thought was a Percocet that he’d bought over the internet. It turned out to be a fake pill that contained illicit fentanyl.[ii] The opioid epidemic began as a situation fuelled by prescription painkillers has evolved into a crisis driven by synthetic opioids, predominantly illicit fentanyl and fentanyl analogues.[iii] More and more people are dying from opioid overdoses, and it’s predicted the deaths could rise to 1.2 million by 2029.[iv] It can be hard to comprehend the enormity of this number or feel its potential impact at a time that’s half a decade from now. It is perhaps easier but no less stark to consider that in 2022, an average of 22 adolescents (people aged 10-19) died of drug overdoses in the US every week - the equivalent of a classroom of young people.[v] Between 2019 and 2020, overdose deaths in young people aged between 14 and 18 years increased by 94.03%, and between 2020 and 2021, they rose by 20.05%.[vi] The rise in young people’s deaths is happening despite a fall in drug use among young people and is strongly associated with the rise in counterfeit pills.

 

Illicitly drug manufacturers are pressing fentanyl into counterfeit pills

Illicitly manufactured fentanyl and other synthetic opioids have been part of the illegal drug market for the last several years and are now the most commonly found drugs involved in overdose deaths.[vii] Fentanyl is up to 50 times stronger than heroin and 100 times stronger than morphine.[viii] The legal version, or FDA approved fentanyl, is used by physicians to treat patients with severe pain, such as following surgery, or late-stage cancer. Illicit fentanyl is made using chemical processes so it can be produced in large quantities, cheaply and quickly. Drug manufacturers are pressing fentanyl into counterfeit pills that are made to look just like legitimate prescription drugs, such as oxycodone (ie: Percocet) and benzodiazepines (ie: Xanax).

 

A tiny amount of fentanyl can be deadly

The increasing prevalence of counterfeit pills in the US is particularly concerning for young people, who may be experimenting with prescription pills and are unaware of the dangers. Illicit fentanyl is so potent that just a tiny amount can be deadly and someone buying a pill would have no way of knowing what it contains without testing it. The overdose risks are even greater for those who don’t have an opioid use disorder and may be experimenting with drugs for the first time. Data from July 2019-December 2019 to July 2021–December 2021 for adolescents showed that 83.9% of deaths involved illicit fentanyl but only 35% had a known history of taking opioids, and counterfeit pills were detected in 24.5% of overdose deaths.[ix]

 

Buying online is a seemingly easy way for young people to get pills

Young people are more likely than adults to engage in behaviours that put them at risk of harm.[x] Their brains are still developing, and the prefrontal cortex, the area responsible for rational thinking and decision making, matures in someone’s mid-to-late twenties. Teenagers are influenced by peer relationships and are more likely to experiment socially, which can lead to positive and negative behaviors. This, coupled with the stresses that they often face related to, friendship issues, exams, going to college and entering the world of work, can trigger experimentation with drugs and alcohol. Mental health conditions are known to increase a person’s risk of using substances. Adolescent mental health was disproportionately affected during the pandemic and declared to be a national emergency in 2021.[xi] Buying online is a seemingly easy way for young people to get pills and drug traffickers are targeting young people on social media by using colorful icons and emojis to promote counterfeit pills.[xii] They’re a powerful way for dealers to sell to young people who are at increased risk of making poor decisions and acting impulsively due to their undeveloped brains.

 

Social media companies are taking actions curbing the development

The Drug Enforcement Agency (DEA) says that it’s working with social media companies and on the Dark Web to catch people using these means to sell drugs.[xiii] Social media companies are also taking action to prevent harm on their sites. For example, Facebook is using proactive detection technologies to find and stop drug-related content.[xiv] However, with  7 out of every 10 fake fentanyl pills containing a potentially lethal dose, there’s so much more to do.[xv] Adolescents need to know about counterfeit pills and how they can keep themselves and their friends safe.[xvi] By giving people the knowledge they need to make informed decisions, we can protect more lives and reduce the stigma associated with mental illness and opioid use disorder.

 

Educating young people is paramount

By breaking the chain between dealers and the adolescents buying pills from them, we can change the drug landscape and make it harder to sell to our children. Educating young people about how to recognize an overdose is paramount, particularly in light of the potency of illicit fentanyl and how quickly it acts. Access to rescue medications is essential, as well as knowing what to do in the critical moments that could be the difference between life and death. We all have a responsibility to give adolescents and the people they interact with at schools, colleges, and in social spaces the knowledge and tools they need to stay safe, make healthy choices and have equitable access to high quality and holistic healthcare.

 

Written by Georgina Hoy

 

  


For further information, please contact:

 

Lena Wange, IR & Communications Director

E-mail: ir@orexo.com

 

About Orexo
Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2023 amounted to SEK 639 million, and the number of employees to 116. Orexo is listed on Nasdaq Stockholm's main list and is available as an ADR on OTCQX (ORXOY) in the US.

 

For more information about Orexo please visit, www.orexo.com. You can also follow Orexo on X, LinkedIn, and YouTube and, also read our blog.

 

 

[i] https://www.dea.gov/onepill

[ii] https://songforcharlie.org

[iii] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154745/

[iv] https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(22)00043-3/fulltext

[v] https://www.newswise.com/pdf_docs/170449618370215_FriedmanTeenOD2022.pdf

[vi] https://jamanetwork.com/journals/jama/fullarticle/2790949

[vii] https://pubmed.ncbi.nlm.nih.gov/32191688/

[viii] https://www.cdc.gov/stopoverdose/fentanyl/index.html

[ix] https://www.cdc.gov/mmwr/volumes/71/wr/mm7150a2.htm

[x] https://www.nimh.nih.gov/health/publications/the-teen-brain-7-things-to-know

[xi] https://www.aap.org/en/advocacy/child-and-adolescent-healthy-mental-development/aap-aacap-cha-declaration-of-a-national-emergency-in-child-and-adolescent-mental-health/?_ga%C2%A0=%C2%A02.148070580.226118470.1666026568-1362783567.1666026568

[xii] https://www.dea.gov/sites/default/files/2021-12/Emoji%20Decoded.pdf

[xiii] https://www.dea.gov/stories/2021/2021-07/2021-07-23/counterfeit-drugs-social-media

[xiv] https://about.fb.com/news/2022/03/community-standards-enforcement-report-q4-2021/

[xv] https://www.dea.gov/onepill

[xvi] https://songforcharlie.org/take-action/